WADA, Naoki et al. Elevated Serum Growth Differentiation Factor 15 Levels as a Potential Biomarker of the Efficacy of Imeglimin in Individuals With Type 2 Diabetes Mellitus: An Exploratory Study. Journal of Clinical Medicine Research, Toronto, Canada, v. 16, n. 10, p. 503–508, 2024. DOI: 10.14740/jocmr6031. Disponível em: https://jocmr.elmerjournals.com/jocmr/article/view/6031.. Acesso em: 21 nov. 2024.